Carnitines Increase Plasma Levels of Adenosine and ATP in Humans

Abstract

In order to help to clarify the mode of action of carnitine derivatives, plasma levels of adenosine, ATP and inosine were evaluated following the infusion of 0.75, 0.50 and 0.25 mg/kg/min propionyl-L-carnitine (PLC) for 30 min in patients affected with peripheral arterial disease. Moreover, the effects of 0.75 mg/kg/min acetyl-L-carnitine (ALC) and L-carnitine (LC) were studied in the same conditions. Finally, the activity of 7.5 mg/kg/min PLC administered for 3 min was also evaluated. PLC and ALC produced a significant increase in plasma levels of adenosine and ATP, whereas LC induced less relevant changes. The administration of the compounds did not affect the adenosine/inosine ratio. Peak plasma levels of adenosine preceded in any case those of ATP. The possibility can be suggested that the pharmacological activity of PLC, ALC, and LC may be mediated, at least in part, by an interference with the endogenous purine system. Since these effects may be related to physiological mechanisms of tissue protection, new pharmacological perspectives for the compounds may arise.

Extracellular ATP Increases <i>L</i>-Carnitine Transport and Content in C2C12 Cells

“…Our hypothesis is that ATP may act as a signal in muscle. Interestingly, it has also been shown [29] that L -carnitine was able to increase ATP levels in plasma. Thus a cross talk between ATP release and L -carnitine may also be hypothesized.…”

Exploratory Open Label, Randomized Study of Acetyl- and Propionylcarnitine in Chronic Fatigue Syndrome

“…When this is the case, a preferential uptake of acetylcarnitine by brain and a preferential uptake of propionylcarnitine by heart are less likely, because OCTN2 is also present in muscle and several other cells. Perhaps another messenger contributes to, or is involved in, the action of the carnitine esters, such as purines (34) or cortisol.…”

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression

“…14 Second, ALCAR increases plasma levels of adenosine and ATP, 15 with the rise in adenosine levels preceding the rise in ATP. Third, ALCAR restores ammonia-induced depletion of brain energy stores in Sparse-fur mice which have elevated ammonia and glutamine levels.…”